Biomedical Bridge BUilders Initiative
BU Biomedical Engineering and the BU Clinical and Translational Science Institute have established a new collaborative program, the Biomedical Bridge BUilders Initiative. It is designed to accelerate the commercialization of clinician-inspired medical device innovations by partnering with graduate engineering biodesign and product development student teams.
Bridge BUilders invites physicians, dental clinicians and other members of the BU Medical Campus to submit a short (one page or less) description of a medical device clinical challenge. These descriptions can be an early product idea or a project that is already underway that could benefit from a team of graduate biomedical engineers, trained in the biodesign product development process. The graduate students selected for each project work part-time under clinical guidance while they complete their Masters Graduate studies at the BU College of Engineering.
This program was initiated during the Fall, 2016 semester with a neonatal monitoring project under the guidance of Dr. Alan Fujii. During its first year, this project completed the initial phase of verification testing, submitted and received IRB approval, and conducted the first series of clinical studies.
The second project is developing a robotic retraction system under the guidance of Dr. Karl Karlson, that will facilitate the exposure of the IMA during open-heart surgical procedures.
Dr. Keith Davies is the Clinical Advisor for a project that will redefine the cranial support system for pediatric neuro surgery.
Dr. Praveen Govender and a team of graduate bioengineers are seeking IRB approval to discuss the clinical requirements and quality of life experiences directly with COPD patients prior to designing a new generation of pulmonary support devices.
The Bridge BUilders Initiative is now exploring clinical challenges for the next cycle of collaboration.
If your idea is selected, you will be invited to serve as the Primary Clinical Advisor to the biomedical engineering team, meet with them on a regular basis, and serve as their sponsor for their Clinical Observership so that they can see the current Standard of Care first-hand.
Related IP resulting from inventions will be assigned to Boston University or BMC under current Patent Policies. We expect each initiative to generate at least one Invention Disclosure.
Please contact us at firstname.lastname@example.org.